Emergent Biosolutions
EBS
EBS
255 hedge funds and large institutions have $1.72B invested in Emergent Biosolutions in 2022 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 78 increasing their positions, 95 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
5% less capital invested
Capital invested by funds: $1.81B → $1.72B (-$96.4M)
18% less repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 95
Holders
255
Holding in Top 10
1
Calls
$4.92M
Puts
$2.67M
Top Buyers
| 1 | +$26.9M | |
| 2 | +$20.7M | |
| 3 | +$17.9M | |
| 4 |
Renaissance Technologies
New York
|
+$14.7M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$14.1M |
Top Sellers
| 1 | -$42.3M | |
| 2 | -$33.4M | |
| 3 | -$29.4M | |
| 4 |
SCM
Snyder Capital Management
San Francisco,
California
|
-$19.7M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$16.8M |